Clinical implications and future possibilities of fecal microbiota transplantation (FMT) are identified. FMT is an innovative therapy with incredible potential for treating gastrointestinal and other microbially-driven conditions. While more research and fine tuning is needed before it becomes a mainstream therapy, its clinical implications are growing.

This latest review study identifies FMT as a treatment for ulcerative colitis, irritable bowel syndrome, and hepatic encephalopathy. The study predicts that FMT will be an accepted treatment for many other conditions in the future. Annual Review of Medicine

Takeaway: While researchers are excited about the potential benefits, other studies show underwhelming results from FMT. Additional research, especially in the area of super donors is needed, as well as other environmental factors that could negatively impact fecal transplant therapy. Coupling FMT with nutrition interventions that focus on high fiber, whole foods and plant-based diets is imperative for success, as is minimizing/eliminating medication use (especially those that are harmful to the microbiome) before, during, and following the transplant. Studies that incorporate these dietary and lifestyle factors will help uncover the true clinical benefits of FMT.